Skip to main content
. 2011 Aug 1;4(4):212–221. doi: 10.1593/tlo.11106

Table 1.

Associations between Chk1, Chk2, and MCM3 and Patient and Tumor Characteristics in Cohorts 1 and 2.

Cohort 1 2



Variable CHK1 CHK2 MCM3 Chk1 Chk2 MCM3
Age
R 0.102 0.069 0.168 -0.009 0.038 0.126
P .1 .265 .006 .914 .652 .139
n 263 263 263 141 145 140
Differentiation grade
R 0.329 0.186 0.323 0.328 0.270 0.286
P <.001 .003 <.001 <.001 .001 .001
n 263 260 260 141 145 140
Clinical stage
R 0.13 0.108 0.141 0.129 0.116 0.181
P .035 .080 .022 .141 .185 .04
n 263 263 263 131 133 130
RBM3
R -0.247 -0.192 -0.253 0.126 0.074 0.074
P <.001 .002 <.001 .138 .38 .386
n 263 263 263 140 143 140
CHK1/Chk1
R 0.440 0.599 0.451 0.462
P <.001 <.001 <.001 <.001
n 263 263 139 137
CHK2/Chk2
R 0.440 0.412 0.451 0.509
P <.001 <.001 <.001 <.001
n 263 263 139 139

n indicates number of tumor samples; R, Spearman correlations coefficient.

P < .005 in bold.

HHS Vulnerability Disclosure